The Relationship Between Self-disclosure, Perceived Social Support and Reproductive Concerns

June 13, 2023 updated by: The First Affiliated Hospital of Soochow University

How Self-disclosure Influences Reproductive Concerns Among Young Male Cancer Patients? The Mediating Role of Perceived Social Support

Participants were recruited from oncology units in two hospitals in Shanxi, China using a convenience sampling.Data were collected using a self-report questionnaire consisting of demographic and disease-related characteristics, and instruments measuring self-disclosure, social support and reproductive concerns.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
    • Shanxi
      • Taiyuan, Shanxi, China, 030200
        • Recruiting
        • Shanxi Bethune Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants were recruited from oncology units in two hospitals in Shanxi, China using a convenience sampling. The eligible participants were invited to complete the questionnaire after they agree to participate.

Description

Inclusion criteria : ① male; ② Age 18-40 years old; ③ Diagnosed with cancer for 1 year or more; ④ Know the disease; ⑤ Clear mind, able to understand and cooperate with the investigation; ⑥ Sign informed consent to participate in the study voluntarily. Exclusion criteria: ① There were serious primary diseases of liver, kidney, hematopoietic, and serious organ failure; ② He has a history of mental illness, personality disorder, cognitive impairment, and organic brain disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participants characteristics
Time Frame: once
Demographic and disease related characteristics included age, marital status, fertility status, payment method of medical expenses, primary caregiver, family history, treatment method, fertility intention, etc.
once
self-disclosure
Time Frame: once
Distress Disclosure Index (DDI) was used to evaluated the level of self-disclosure of young male cancer patients
once
perceived social support
Time Frame: once
the Perceived Social Support Scale (PSSS) was used to evaluate the level of perceived social support of young male cancer patients which includes 3 dimensions which are named by friend support, family support and other support, with a total of 12 items.
once
reproductive concerns
Time Frame: once
the Reproductive concerns after cancer scale-male（RCAC-M） was used to evaluata the level of reproductive concerns in young male cancer survivors.
once

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The First Affiliated Hospital of Soochow University

Investigators

  • Study Director: Jun Zhao, The First Affiliated Hospital of Soochow University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2023

Primary Completion (Estimated)

June 30, 2023

Study Completion (Estimated)

August 1, 2023

Study Registration Dates

First Submitted

June 13, 2023

First Submitted That Met QC Criteria

June 13, 2023

First Posted (Actual)

June 22, 2023

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 13, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 20230614

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Survivors of Young Male Cancer Survivors

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe